Bollard Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.16B | Sell |
18,532,173
-468,296
| -2% | -$37.5M | 34.26% | 1 |
|
|
2025
Q4 | $1.81B | Sell |
19,000,469
-733,104
| -4% | -$71.9M | 45.28% | 1 |
|
|
2025
Q3 | $1.93B | Sell |
19,733,573
-345,870
| -2% | -$35.8M | 45.28% | 1 |
|
|
2025
Q2 | $2.16B | Sell |
20,079,443
-411,383
| -2% | -$41.6M | 49.31% | 1 |
|
|
2025
Q1 | $2.07B | Sell |
20,490,826
-242,400
| -1% | -$24.4M | 54.28% | 1 |
|
|
2024
Q4 | $1.85B | Sell |
20,733,226
-510,325
| -2% | -$44.9M | 51.33% | 1 |
|
|
2024
Q3 | $1.78B | Sell |
21,243,551
-419,750
| -2% | -$33.1M | 47.36% | 1 |
|
|
2024
Q2 | $1.67B | Sell |
21,663,301
-335,320
| -2% | -$24.5M | 47.07% | 1 |
|
|
2024
Q1 | $1.51B | Sell |
21,998,621
-392,890
| -2% | -$25.3M | 45.57% | 1 |
|
|
2023
Q4 | $1.29B | Sell |
22,391,511
-953,215
| -4% | -$50.9M | 45.01% | 1 |
|
|
2023
Q3 | $1.23B | Sell |
23,344,726
-330,355
| -1% | -$17.3M | 45.36% | 1 |
|
|
2023
Q2 | $1.28B | Sell |
23,675,081
-432,545
| -2% | -$22.6M | 43.56% | 1 |
|
|
2023
Q1 | $1.21B | Sell |
24,107,626
-353,200
| -1% | -$16.6M | 43.57% | 1 |
|
|
2022
Q4 | $1.13B | Sell |
24,460,826
-1,278,765
| -5% | -$55.4M | 43.24% | 1 |
|
|
2022
Q3 | $997M | Sell |
25,739,591
-456,400
| -2% | -$18.3M | 41.89% | 1 |
|
|
2022
Q2 | $976M | Sell |
26,195,991
-437,881
| -2% | -$17.8M | 39.56% | 1 |
|
|
2022
Q1 | $1.18B | Sell |
26,633,872
-329,826
| -1% | -$14.3M | 37.74% | 1 |
|
|
2021
Q4 | $1.15B | Sell |
26,963,698
-193,215
| -0.7% | -$8.12M | 36.67% | 1 |
|
|
2021
Q3 | $1.18B | Sell |
27,156,913
-2,628,079
| -9% | -$116M | 38.6% | 1 |
|
|
2021
Q2 | $1.27B | Sell |
29,784,992
-1,590,099
| -5% | -$66.9M | 40.38% | 1 |
|
|
2021
Q1 | $1.21B | Buy |
31,375,091
+77,380
| +0.2% | +$2.93M | 42.48% | 1 |
|
|
2020
Q4 | $1.13B | Sell |
31,297,711
-727,250
| -2% | -$26.2M | 41.9% | 1 |
|
|
2020
Q3 | $1.22B | Sell |
32,024,961
-389,132
| -1% | -$15M | 44.1% | 1 |
|
|
2020
Q2 | $1.14B | Sell |
32,414,093
-250,945
| -0.8% | -$9.04M | 44.71% | 1 |
|
|
2020
Q1 | $1.07B | Sell |
32,665,038
-483,945
| -1% | -$18.9M | 47.37% | 1 |
|
|
2019
Q4 | $1.5B | Sell |
33,148,983
-223,605
| -0.7% | -$9.36M | 48.66% | 1 |
|
|
2019
Q3 | $1.36B | Sell |
33,372,588
-144,338
| -0.4% | -$6.12M | 47.69% | 1 |
|
|
2019
Q2 | $1.44B | Sell |
33,516,926
-65,200
| -0.2% | -$2.51M | 49.64% | 1 |
|
|
2019
Q1 | $1.29B | Hold |
33,582,126
| – | – | 48.65% | 1 |
|
|
2018
Q4 | $1.19B | Buy |
33,582,126
+14,000
| +0% | +$508K | 52.34% | 1 |
|
|
2018
Q3 | $1.29B | Buy |
33,568,126
+56,622
| +0.2% | +$1.98M | 51.96% | 1 |
|
|
2018
Q2 | $1.1B | Sell |
33,511,504
-143,537
| -0.4% | -$4.33M | 50.34% | 1 |
|
|
2018
Q1 | $919M | Sell |
33,655,041
-199,076
| -0.6% | -$5.41M | 45.71% | 1 |
|
|
2017
Q4 | $839M | Buy |
33,854,117
+118,050
| +0.3% | +$3.26M | 40.34% | 1 |
|
|
2017
Q3 | $984M | Hold |
33,736,067
| – | – | 51.88% | 1 |
|
|
2017
Q2 | $935M | Sell |
33,736,067
-1,422,495
| -4% | -$37.8M | 50.51% | 1 |
|
|
2017
Q1 | $874M | Buy |
35,158,562
+26,300
| +0.1% | +$640K | 50.14% | 1 |
|
|
2016
Q4 | $760M | Buy |
35,132,262
+481,488
| +1% | +$10.5M | 49.57% | 1 |
|
|
2016
Q3 | $825M | Buy |
34,650,774
+853,713
| +3% | +$20.4M | 52.75% | 1 |
|
|
2016
Q2 | $790M | Buy |
33,797,061
+7,727,095
| +30% | +$167M | 53.96% | 1 |
|
|
2016
Q1 | $490M | Sell |
26,069,966
-2,000
| -0% | -$35.1K | 39.49% | 1 |
|
|
2015
Q4 | $481M | Sell |
26,071,966
-300
| -0% | -$5.38K | 39.58% | 1 |
|
|
2015
Q3 | $428M | Sell |
26,072,266
-319,743
| -1% | -$5.47M | 35.09% | 1 |
|
|
2015
Q2 | $467M | Hold |
26,392,009
| – | – | 35.28% | 1 |
|
|
2015
Q1 | $468M | Hold |
26,392,009
| – | – | 34.88% | 1 |
|
|
2014
Q4 | $350M | Hold |
26,392,009
| – | – | 30.86% | 1 |
|
|
2014
Q3 | $312M | Buy |
26,392,009
+11,525
| +0% | +$145K | 29.43% | 1 |
|
|
2014
Q2 | $337M | Sell |
26,380,484
-121,130
| -0.5% | -$1.58M | 32.55% | 1 |
|
|
2014
Q1 | $358M | Sell |
26,501,614
-351,500
| -1% | -$4.61M | 36.24% | 1 |
|
|
2013
Q4 | $323M | Buy |
26,853,114
+746,130
| +3% | +$8.82M | 35.59% | 1 |
|
|
2013
Q3 | $306M | Buy |
26,106,984
+14,273,365
| +121% | +$154M | 36.05% | 1 |
|
|
2013
Q2 | $110M | Buy |
+11,833,619
| New | +$100M | 21.1% | 1 |
|
Other funds holding BSX
VCM
VPM
Bollard Group's BSX Position: Q1 2026 in Review
Bollard Group reduced its Boston Scientific (BSX) stake by 2.5% in Q1 2026, selling an estimated $37.5M and leaving 18,532,173 shares worth $1.16B. The position accounts for 34.26% of the portfolio, ranked #1.
Bollard Group first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.16B in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Bollard Group held 18,532,173 shares of Boston Scientific worth $1.16B as of Q1 2026.
- Bollard Group sold 468,296 Boston Scientific shares in Q1 2026, an estimated $37.5M.
- Boston Scientific made up 34.26% of Bollard Group's portfolio in Q1 2026, its #1 holding.
- Bollard Group first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- Bollard Group's Boston Scientific position peaked at $2.16B in Q2 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Bollard Group's 13F filing for Q1 2026, filed 14 May 2026.